Patient Centric Sampling to Enable Decentralization of Clinical Trials

Monday, October 17, 2022

11:00 AM – 12:00 PM ET

Location:360 Stage #4, Exhibit Hall A&B

Presented By

Partner Presentation Speaker(s)

Stephanie Cape, PhD (she/her/hers)

Head of R&D - Scientific Affairs, Clinical Trials Testing Solutions
Labcorp
Madison, Wisconsin

Decentralized and hybrid clinical trials aim to lessen patient burden by reducing practical barriers to trial participation thus improving patient access, recruitment, and retention. Laboratory sampling for pharmacokinetic, safety and biomarker measurements must be considered to fully realize the value of decentralization. Here, different approaches to bring the sampling event closer to the patient will be reviewed with a focus on innovative solutions in the pipeline.

Learning Objectives:

Understand patient centric sampling and why it is important within decentralized clinical studies.
Understand the various technologies available for bringing laboratory sampling closer to the patient,
Understand the importance of integrating decentralized clinical trials solutions in order to reduce patient burden.